Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 29, 2015 09:00 ET | Source: Qu Biologics

Qu Biologics Granted U.S. Patent for Use of Staphylococcus Aureus-Based Immunotherapies to Treat Melanoma

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 29, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
August 31, 2015 09:00 ET | Source: Qu Biologics

Qu Biologics Opens Additional Ulcerative Colitis Clinical Trial Sites in Edmonton and Hamilton

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 31, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
July 28, 2015 19:33 ET | Source: Qu Biologics

Qu Biologics Begins Phase 2 Clinical Trial in Ulcerative Colitis

VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 28, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
July 14, 2015 09:00 ET | Source: Qu Biologics

Qu Biologics Begins Research Collaboration with Dr. Bruce Vallance at the University of British Columbia to Study SSI Treatment for Inflammatory Bowel Disease

VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 14, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
June 24, 2015 07:30 ET | Source: Sonoco Products Company

Sonoco ThermoSafe Launches Reusable Container for Blood Transport and Storage

ARLINGTON HEIGHTS, Ill., June 24, 2015 (GLOBE NEWSWIRE) -- Sonoco ThermoSafe, a unit of Sonoco (NYSE:SON) and a leading supplier of temperature assurance packaging, has launched a revolutionary...
June 10, 2015 09:40 ET | Source: Qu Biologics

Qu Biologics Appoints Jim Pankovich as Vice President, Clinical Operations and Drug Development

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 10, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
May 11, 2015 10:05 ET | Source: Qu Biologics

Qu Biologics Granted European Patent for Use of Bacterial Compositions for the Treatment of Cancer

VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 11, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
April 30, 2015 15:31 ET | Source: Qu Biologics

Qu Biologics to Present at Bloom Burton Healthcare Investor Conference

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 30, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
April 24, 2015 15:05 ET | Source: Qu Biologics

Qu Biologics Opens Clinical Trial Sites in Edmonton and Toronto for Crohn's Disease Clinical Trial

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 24, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
March 31, 2015 09:40 ET | Source: Qu Biologics

Qu Biologics Granted U.S. Patent for Use of E. coli to Treat Crohn's Disease

VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 31, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...